Get the Stockscreener App
36.65
14.60%
4.67
After Hours:
35.20
-1.45
-3.96%
Apollomics Inc stock is traded at $36.65, with a volume of 142.23K.
It is up +14.60% in the last 24 hours and up +98.83% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$31.98
Open:
$32
24h Volume:
142.23K
Relative Volume:
2.19
Market Cap:
$40.44M
Revenue:
-
Net Income/Loss:
$-53.86M
P/E Ratio:
-0.6728
EPS:
-54.4704
Net Cash Flow:
$-28.76M
1W Performance:
+98.83%
1M Performance:
+98.83%
6M Performance:
+515.97%
1Y Performance:
+197.48%
1-Day Range:
$32.00
$40.02
1-Week Range:
$18.25
$42.12
52-Week Range:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
36.65 | 68.54M | 0 | -53.86M | -28.76M | -54.47 |
|
LION
Lionsgate Studios Corp
|
5.91 | 1.74B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
21.10 | 1.03B | 0 | 0 | 0 | 0.00 |
|
HOND
Hcm Ii Acquisition Corp
|
25.92 | 668.73M | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.02 | 590.82M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.30 | 565.34M | 0 | 0 | 0 | 0.00 |
Apollomics Inc Stock (APLM) Latest News
Will earnings trigger a reversal in Apollomics Inc.2025 Key Highlights & Community Verified Swing Trade Signals - newser.com
Aug Mood: Will Apollomics Inc. Equity Warrant stock outperform Dow Jones index2025 Geopolitical Influence & Reliable Price Action Trade Plans - Trung tâm Dự báo KTTV quốc gia
Will Apollomics Inc. Equity Warrant stock recover after recent dropEntry Point & Stepwise Trade Signal Implementation - newser.com
Biotech Shares Jump On Breakthroughs In Tremor And Pain Treatments - Finimize
Why Apollomics Stock Nosedived 16% After-Hours Today - Asianet Newsable
Apollomics Receives Compliance Notification From Nasdaq - MarketScreener
Apollomics announces continued listing on Nasdaq following hearing cancellation - MarketScreener
Apollomics Inc. Secures Continued Listing on Nasdaq Following Compliance Notification - Quiver Quantitative
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation - GlobeNewswire
Nasdaq Cancels Hearing; Apollomics to Remain Listed After Staff Finds Compliance on Oct. 14, 2025 - Stock Titan
Is Apollomics Inc. stock attractive for hedge funds2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
Full technical analysis of Apollomics Inc. Equity Warrant stockPortfolio Update Summary & Risk Managed Trade Strategies - newser.com
Is Apollomics Inc. stock poised for growthSell Signal & Safe Entry Momentum Tips - newser.com
Nasdaq to resume trading of Apollomics shares after month-long halt - Investing.com Nigeria
Nasdaq to resume trading of Apollomics shares after month-long halt By Investing.com - Investing.com South Africa
Nasdaq Resumes Trading in Apollomics Inc. - The Manila Times
Nasdaq Announces Resumption of Trading for Apollomics Inc. Class A Shares and Warrants on October 15, 2025 - Quiver Quantitative
NASDAQ resumes trading in Apollomics shares and warrants - StreetInsider
GlobeNewswire by Notified - The Manila Times
Custom watchlist performance reports with Apollomics Inc.July 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Apollomics Inc. Provides Operational Update and Reaffirms Commitment to APL-101 Development Following Leadership Changes and New Funding - Quiver Quantitative
Apollomics says company has reversed its wind-up plans - MarketScreener
$4.1M PIPE funds Apollomics' reversal of wind‑up to continue global Phase 2 APL‑101 (280+ patients) - Stock Titan
Apollomics, Inc. Company Operational Continuity Update - GlobeNewswire
Will Apollomics Inc. Equity Warrant stock reach Wall Street targets2025 Analyst Calls & AI Driven Stock Reports - newser.com
Will breakout in Apollomics Inc. Equity Warrant lead to full recovery2025 Momentum Check & Free Community Consensus Stock Picks - newser.com
Should you hold or exit Apollomics Inc. Equity Warrant nowJobs Report & Free Accurate Trade Setup Notifications - newser.com
Intraday pattern recognizer results for Apollomics Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Reversal indicators forming on Apollomics Inc. stock2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Is Apollomics Inc. Equity Warrant reversing from oversold territorySwing Trade & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-10 10:02:49 - newser.com
What machine learning models say about Apollomics Inc.2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Has Apollomics Inc. Equity Warrant formed a bullish divergenceJobs Report & Daily Entry Point Alerts - newser.com
Published on: 2025-10-10 05:12:33 - newser.com
Published on: 2025-10-10 04:27:39 - newser.com
Detecting price anomalies in Apollomics Inc. with AIQuarterly Market Summary & High Return Stock Watch Alerts - newser.com
Apollomics, Inc. (NASDAQ:APLMW) Sees Large Increase in Short Interest - Defense World
Best data tools to analyze Apollomics Inc. stock2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - newser.com
What dividend safety score for Apollomics Inc. stockWeekly Investment Report & Fast Entry Momentum Alerts - newser.com
Why Apollomics Inc. Equity Warrant stock is rated strong buy2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Market reaction to Apollomics Inc. Equity Warrant’s recent newsEntry Point & Step-by-Step Swing Trade Plans - newser.com
What indicators show strength in Apollomics Inc.Share Buyback & Verified Entry Point Detection - newser.com
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.22%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):